Sunday, March 02, 2014 12:32:00 PM
"I like this post from just over an hour ago!
You must follow this board already!! "
DD Rante thinks like I do. Elite is gonna be a Monster company. No way Nasrat turns this company over to another. This is now his baby. He has all the makings of a great CEO. Not that Jerry didn't, but Nasrat has the corporate pharma experience. They have known what they have here for a long long time. Now it is coming to fruition.
I'm hoping a partner(s) is not announced until after the FDA approves the ART. In such a case Eilte
will have the bonefides and Big opioid Pharma will have to deal or get left in the dust.
Every single opioid out there can be abused, from codeine to hydrocodone. We are talking about a multibillion dollar company with just the ART. Since this is a plug and play for all opioids the opioid world will be Elite's cultured pearl oyster.
If one factors in ELI-154 and a possible patent app for that again, then the micro pill patent.......... Whammo! Elite has tons of potential.
This ART is huge. No pump here. If Elite slow plays this they could have the whole pharmaceutical opioid world at their doorstep. When the FDA approves this ART that in my opinion is when the fun will start. Maybe a deal has already been cut and maybe not. Maybe one company involved or several.
Elite will be legitimate and Big Pharma will have to pay attention...... or lose market share to those companies that are paying attention. Won't happen overnight, but over time those that get on board
with Elite's ART will be the survivors. The others will just fade away into oblivion.
It is well to remember that the entire universe, with one trifling exception, is composed of others. — John Andrew Holmes
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM